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The structural and/or functional abnormality of the cardiac 
electrovascular system is the most common cause of world mortality 
accounting for 29.0 % of deaths, followed by infectious diseases 
(16.2 %) and cancers (12.6 %) (WHO 2008 report).1 Abnormalities in 
the cardiac electrical system (arrhythmias and sudden death) and/or 
mechanical function (heart failure) constitute one of the major 
causes of disability and death, which heavily burden the health care 
systems across the globe. 
For more than 100 years, 12-lead electrocardiography (ECG) has 
been the standard of care, non-invasive tool, which involves 
measuring electrical potentials from limited sites on the body 
surface to diagnose cardiac disorder, its possible mechanism 
and the likely site of origin. Advances in non-invasive imaging 
technology have yielded tools such as computed tomography (CT), 
magnetic resonance imaging (MRI) and positron emission tomography 
(PET), among several others, which have provided novel insights into 
the clinical physiology, anatomy and pathologies. These non-invasive 
diagnostic methods have also improved patient care by providing 
valuable guidance in the therapeutic management of several 
cardiac and non-cardiac disorders. Many of these modalities have 
replaced the invasive imaging techniques as gold standards (e.g. 
MRI or CT have largely replaced cardiac catheterisation in congenital 
heart problems). 
In cardiac electrophysiology and arrhythmias, several decades 
of research has led to the development of electrocardiographic 
imaging (ECGI), a novel three-dimensional (3D), 252-lead, body surface 
ECG-based, non-invasive epicardial imaging modality. This technique 
images potentials, electrograms and activation sequences (isochrones) 
on the epicardial surface of the heart.2 This tool has been investigated 
in the normal cardiac electrophysiology and various tachyarrhythmic, 
conduction and anomalous depo-repolarisation disorders. It has been 
emerging as a tool of potentially higher clinical value than the 12-lead 
ECG in terms of sensitivity, specificity and accuracy in the diagnostic 
and therapeutic management of cardiac rhythm disorders.
Here we describe the potential of this non-invasive mapping technique 
developed by Rudy2 in identifying the sources of electrical disorders of 
the heart like atrial arrhythmias (premature atrial beat, atrial tachycardia, 
atrial fibrillation), ventricular arrhythmias (premature ventricular beat, 
ventricular tachycardia) and ventricular pre-excitation (Wolff-Parkinson-
White syndrome). In addition, the system has been of clinical value in 
understanding the abnormalities of His-Purkinje conduction (bundle 
branch block, intraventricular conduction disturbance and associated 
heart failure), abnormalities of ventricular action potential (depolarisation 
[Brugada syndrome and repolarisation], long QT and early repolarisation 
syndromes) and in evaluating the impact of drugs on His-Purkinje 
conduction and cardiac action potential.
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Mapping Technique
The signal acquisition from the patient and subsequent computational 
methods used in the reconstruction of non-invasive maps using 
multiple torso electrodes have been previously described.2 Briefly, a 
252-electrode vest is applied to the patient’s torso and connected to 
the non-invasive imaging system, and surface potentials are recorded 
(see Figure 1). It is followed by a non-contrast thoracic CT scan to 
obtain high-resolution images of the heart and the vest electrodes. 
The 3D epicardial bicameral (atria or/and ventricles) geometries are 
reconstructed from segmental CT images. The relative positions of 
body surface electrodes can be visualised on the torso geometry. The 
system reconstructs epicardial potentials, unipolar electrograms and 
activation maps from torso potentials during each beat/cycle using 
mathematical reconstruction algorithms. Details of the mathematical 
methods have been provided in previous publications.3–7 
Normal Cardiac Rhythm
Until the development of body surface imaging modality, normal atrial 
and ventricular excitation could be obtained from invasive cardiac 
catheterisation, intra-operative epicardial mapping8 or mapping 
explanted9 human hearts. With the advent of ECGI, simultaneous 3D 
recording of whole heart activation is feasible in a normal person 
under absolute physiological conditions,10 which have been shown to 
be in accordance with the observations made and therefore precludes 
the need for an invasive approach.8 
On biatrial maps of sinus rhythm, the activation starts in the right 
atrium at the anatomical location of the sinoatrial node, where the 
impulse originates. The impulse propagates to the rest of the right 
atrium centrifugally and crosses over to the anterior left atrium 
through the anterior interatrial connection (the bundle of Bachmann). 
Posterior-inferior left atrium is activated as the impulse travels 
over the interatrial connection at the ostium of the coronary sinus. 
These two wavefronts converge onto the lateral left atrium, which is, 
hence, the last atrial activation site (see Figure 2 – normal sinus beat 
in the atrium).
In a normal heart, the cardiac impulse is conducted from the atria to 
the ventricles via the endocardially situated atrioventricular bundle 
and the right and left bundle branches of the cardiac conduction 
system. The Purkinje network establishes a broad activation front in 
the endocardium, which is followed by impulse propagation to the 
epicardium; thereby allowing rapid and simultaneous activation and 
contraction of both the ventricules. When the activation wavefront 
arrives from the endocardium, epicardial breakthroughs are 
recorded on the non-invasive imaging tool with rS local electrogram 
morphology at the earliest sites. The regional activation of ventricular 
chamber is temporally variable in normal individuals but its global 
activation largely follows one pattern (i.e. apical to basal). The first 
breakthrough occurs in the right ventricular (RV) anterior paraseptal 
region during early QRS. As the activation spreads in all directions 
from here, additional breakthroughs quickly follow on the RV and left 
ventricular (LV) epicardium. The latter is generated by the activation 
of the anterior branch of the bifurcating left bundle. During mid-QRS, 
more breakthroughs appear in the left-anterior-paraseptal region, 
right-inferior and apical RV region. Thus normal epicardial RV activation is 
caused by the coalescence of multiple quick sequential breakthroughs. 
On the LV, endocardial-to-epicardial propagation activates the anterior 
LV free wall as stated above. Thereafter, the activation spreads from 
apical LV region to its base, such that the posterobasal LV is activated 
at the end of QRS (see Figure 3).
Atrial Arrhythmias
Atrial rhythm disorders include isolated atrial premature beats, atrial 
tachycardias (ATs) and atrial fibrillation (AF). 
Atrial Tachycardia and Premature Beat
Wang et al. reported the first successful use of ECGI in the non-invasive 
diagnosis of the source of a clinical atrial tachycardia.11 ECGI accurately 
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Figure 3: Biventricular Activaton Maps During Impulse 
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Knowing the precise relationship between the electrocardiography (ECG) electrodes and the 
epicardial cardiac surface from the computed tomography (CT) scan, the system solves the 
inverse problem to reconstruct epicardial electrograms and 3D maps such as isopotential 
and isochronal maps. A: 252 electrode vest; B: heart-torso geometry (CT scan); C: acquisition 
of the cardiac signals (forward problem); D: pre or per-procedural instantaneous maps 
(inverse problem).
The red colour in the scale corresponds to the earliest activation and blue to the last.  
LAO = left anterior oblique; LIPV = left inferior pulmonary vein; LSPV = left superior 
pulmonary vein; MA = mitral annulus; RAO = right anterior oblique; RIPV = right inferior 
pulmonary vein; RSPV = right superior pulmonary vein; TA = tricuspid annulus.
MA = mitral annulus; TA = tricuspid annulus.
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located the earliest site of atrial activation during focal AT in 
a patient that had previously undergone two pulmonary vein 
(PV) isolation procedures. The tachycardia was successfully 
terminated with radiofrequencyablation in the non-invasively 
determined location. ECGI can undertake online analysis of one 
ectopic beat and thereby provide global atrial activation patterns 
of sustained as well as transient AT non-invasively. The technique 
therefore has advantage over the sequential mapping technique, a 
diagnostic method employed by current invasive electroanatomic 
systems, which necessitates sustenance of AT or repetitive 
occurrence of ectopic beats, making the approach impractical in 
intermittent events.
Later, Wang et al. also demonstrated the utility of ECGI in the 
non-invasive diagnosis of left atrial macroreentrant AT arising 
in the context of previous AF ablation.12 Atrial tachycardias are 
relatively common in patients with AF who have undergone catheter 
ablation and often require additional mapping and ablation. The system 
is currently able to diagnose macroreentry where AT encompasses 
>75 % of the cycle spread over three or more atrial segment versus 
focal AT diagnosed based on the presence of centrifugal spread of 
activation from a small source (focus). Of note, the localisation of an 
AT by analysis of the standard 12-lead ECG is difficult because 
the interpretation of P-wave morphology recorded on a standard 
ECG may not be valid in patients with diseased atria who have 
undergone circumferential PV isolation combined with ablation of 
biatrial substrate guided by fragmented potentials and/or linear 
lesions (see Figure 4). It should be recognised that ECGI generates 
the global activation map (potential/isochrone) during a single 
AT cycle and is therefore well suited to detect rapidly changing 
arrhythmias. In contrast, point-by-point mapping using the roving 
catheter and contemporary electroanatomic system requires data 
from many sequential beats to construct such maps.
We have prospectively mapped various clinical ATs13 in a wide 
range of patients using electrocardiographic mapping (ECM), a 
non-invasive mapping tool developed for commercial use by 
CardioInsight technologies Inc, Cleveland, OH, US, based on the 
principles of ECGI to evaluate the feasibility of this system in defining: 
•  the mechanism of AT – macroreentrant (perimitral, cavotricuspid 
isthmus-dependent and roof-dependent circuits) versus 
centrifugal focal activation; and 
•  the location (chamber and region) generating the arrhythmia in 
centrifugal ATs (see Figure 5). 
Fifty-two patients (age  61 ± 11 years; 42 male, structural heart disease 
in 18) with clinical AT (mean cycle length 284 ± 85 milliseconds [ms]) 
including those arising de novo, after catheter or surgical AF ablation 
(n-27) and post-atriotomy were included from three world centres.13 
All patients were first mapped bedside using ECM, followed median 
of one day (Inter Quartile Range: 1.7) later by invasive mapping and 
ablation. The invasive operator was blinded to the non-invasive 
diagnosis. Invasive electrophysiological mapping was performed 
using conventional electrogram and 3D electroanatomical mapping 
system (Carto XP, Biosense Webster, US or NavX, St Jude Medical Inc, 
US) guidance. ECMap was considered accurate when the detection 
of the clinical target by ECM matched with that obtained on invasive 
EP mapping and subsequently confirmed by successful ablation. The 
ECM diagnosis was evaluable in 48 of 52 patients. In four patients, 
clinical AT converted to another rhythm (AT and AF in one each and 
sinus in two) before invasive mapping was completed, and therefore, 
these patients were excluded from the comparative analysis. 
Out of 48 evaluable clinical ATs, 27 ATs were diagnosed in the 
electrophysiology (EP) laboratory as macroreentrant and 21 as centrifugal 
arrhythmias. All of them were successfully terminated by ablation 
resulting in sinus rhythm in 44, or to another AT in four. The overall 
diagnostic accuracy of ECM compared with invasive EP diagnosis, 
the gold standard, was 92 % – 100 % in patients without any previous 
ablation and 83  % in patients with previous AF ablation(s). ECM was 
particularly useful and adept at accurately diagnosing centrifugal ATs in 
100 % of patients including 11 (58 %) patients with previous AF ablation. 
In this study, the primary reason of failure to diagnose the arrhythmia 
mechanism in four out of 48 (8  %) evaluable ATs was 2:1 atrio-
ventricular conduction, precluding the selection of a full tachycardia 
cycle (unmasked by QRST complex), which is necessary for ECM single 
cycle analysis. This can be addressed clinically by administration of 
atrioventricular node blockers or simple pacing manoeuvres during 
the invasive procedure to unmask multiple P waves. In addition, some 
post-ablation atria exhibited substantially lower ECG P-wave amplitude, 
which further complicated and challenged the diagnosis, contributing 
to lower accuracy in post-AF ablation ATs (83 %). Since ECM is a single 
beat/cycle mapping technology, noise reduction using a signal-averaging 
algorithm is being investigated with promising results to improve the 
accuracy in low voltage substrate-based arrhythmias. 
A potential limitation of the system is its inability to provide direct 
mapping of the septum. Since the septum is not an epicardial structure 
and therefore not included or displayed on the map, a septal source is 
deduced by demonstrating simultaneous activation of both chambers 
from the interatrial groove. While precise localisation on the septum may 
not be feasible for septal-source ATs, the deductive information 
may suffice with regard to ablation of target in the region of interest. 
Figure 4: A 12-lead Electrocardiography Showing Atrial 
Tachycardia After Pulmonary Vein Isolation and Left  
Atrial Defractionation 
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Although there is evidence for differential activation of the contiguous 
endo-epicardium in the atria (in at least some of its parts), the difference, 
at best, could be considered modest considering that the atrial tissue is 
much thinner in most parts than the ventricular myocardium. 
Atrial Fibrillation
Cuculich et al. studied continuous biatrial epicardial activation patterns 
of human AF using non-invasive electrocardiographic mapping.14 
In the testing phase, mapping accuracy was evaluated by atrial 
pacing in six patients and comparing the maps with co-registered 
CARTO (Biosense Webster, Diamond Bar, California) images. Spatial 
accuracy for determining initiation sites from pacing was six millimetres 
(mm). Additionally, correlative observations from catheter mapping 
and ablation were compared with non-invasive mapping in three 
patients. In the study phase, non-invasive maps during AF in a wide 
range of 26 patients were analysed for mechanisms and complexity. 
The low-amplitude signals of AF were successfully mapped in 97 % of 
patients. The diverse but co-existing and reproducible (over the data 
collection period of minutes to hours) biatrial activation patterns during 
AF included multiple wavelets (1–5 and most commonly two wavelets) 
in 92 %, ill-sustained rotors in persistent AF involving the posterior 
left atrium near the PV ostia predominantly and the anterolateral right 
atrium rarely in 15 %, pulmonary venous foci in 69 %, non-PV foci in 
62 %, and less commonly a single-wave re-entry involving both the 
atria in the same order of decreasing complexity. The complexity of 
the patterns of AF generally increased with the duration of uninterrupted 
Figure 5: Focal Source Premature Ectopic Complex Arising from the Anterior Wall of the Right Superior Pulmonary 
Venous Ostium was Mapped Accurately with the ECM System (Isochronal Map Shown) and Successfully Ablated at 
the Corresponding Site Seen on the Fluoroscopic Image. Premature Ectopic Complex Terminated After 9 Seconds of 
Radiofrequency Application 
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Figure 6: Biventricular Isopotential Map (Yellow Colour Denotes the Earliest Activation) During Premature Ventricular 
Complex (12-Lead ECG). Inserted is an Epicardial Virtual Electrogram (QS Morphology) from the Earliest Site. The 
Fluoroscopic Image at the Site of Successful Ablation and Local Intracardiac Electrogram are Shown As Well
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AT = atrial tachycardia; IVC = inferior vena cava; LAA = left atrial appendage; LAO = left anterior oblique; ms = milliseconds; PAC = premature atrial complex; RAA = right atrial appendage;  
SVC = superior vena cava. 
Ao = aortic root; LAD = left anterior descending artery; LAO = left anterior oblique; MV = mitral valve; PA = pulmonary artery; TV = tricuspid valve.
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AF and therefore it was higher in persistent AF than paroxysmal AF. 
Among persistent and long-standing persistent AF, there was overlap in 
the complexity of these patterns.
In a recent development, phase technique to map AF simultaneously 
displays co-existence of various mechanisms during the recording period.
Ventricular Arrhyhtmias
Ventricular Tachycardia and Premature Beat
Intini et al. used the electrocardiomapping technique for the first 
time clinically to guide diagnosis and therapy of a focal ventricular 
tachycardia (VT) in a young athlete.15 Isolated ventricular ectopic 
beats of an identical morphology to the sustained tachycardia were 
mapped prior to the invasive procedure, and their origin was localised 
to the LV apical diverticulum. Importantly, the QS wave pattern of the 
re-constructed electrogram from the site of origin of the ectopies 
indicated that those beats were emanating from the ventricular 
epicardium at that site. Figure 6 shows an example of a similar 
premature beat. In the EP laboratory, the sustained tachycardia was 
induced in the presence of isoproterenol. Intracardiac activation 
mapping during tachycardia demonstrated earliest activation in 
the apical LV diverticulum. During sinus rhythm, pace map at that 
site was remarkably similar to the tachycardia morphology in 12/12 
ECG leads. Electroanatomic 3D mapping (CARTO) of the LV chamber 
performed during the ectopy also identified the earliest site of 
activation at the LV apex in the region of the diverticulum, consistent 
with a focal origin of the tachycardia. Later, transient resolution of 
the tachycardia during several radiofrequency applications delivered 
endocardially to the area, supported an epicardial origin for the 
arrhythmia. On invasive epicardial approach, the earliest activation of 
the ventricular ectopy was identified in a region of low voltage (<1.45 
millivolts [mV]) at the LV apex overlying the region of endocardial 
abnormality. Cryolesions (-70 degree Celsius [°C]) were placed in the 
low-voltage area. Close proximity to the phrenic nerve, assessed by 
capture during pacing, precluded complete ablation of the region 
resulting in recurrence of the arrhythmia.
Figure 7: Biventricular Isopotential Map (Yellow Colour Denotes the Earliest Activation) During Pre-excitation from 
a Right Posteroseptal Accessory Pathway (12-lead ECG), which was Successfully Ablated (Fluoroscopic Image) at 
the Corresponding Site. Also Inserted is a Virtual Electrogram (QS Morphology) from the Site of Earliest Ventricular 
Activation Over the Manifest Pathway
Figure 8: Intraprocedural Use of Biventricular Electrocardiomapping to Guide the Left Ventricular Lead Placement for 
Cardiac Resynchronisation Therapy 
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AO = aortic root; LAO = left anterior oblique; MV = mitral valve; TV = tricuspid valve.
LV = left ventricular; ms = milliseconds; RV = right ventricular.
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Wang et al. studied 26 ventricular arrhythmias in 25 patients 
(tachycardias [n-9], premature beats) using a non-invasive 
electrocardiomapping technique prior to (n-19) and during (n-4) the 
invasive procedure to localise the site of origin of the arrhythmia, 
to evaluate the mechanism based on the pattern of arrhythmia 
propagation and its relationship to the myocardial substrate, and 
to correlate the site of origin with local electrogram morphology 
(QS wave for epicardial origin, rS complex for intramural or 
endo-cardial origin).16 ECGI correctly identified the right or left 
ventricular location of the arrhythmia in 100 % of studies (n-23). 
When the specific locations within each ventricle were compared, 
non-invasive ECGI was in agreement with the invasive EP study in 10 out 
of 11 RV sites (91 %) and in 11 out of 12 LV sites (92 %). For the two 
patients with discrepancies between invasive and non-invasive 
modalities, the discrepant locations were in proximity to each 
other. For the patient with right posteroseptal RV location, ECGI 
imaged the right posterolateral base as the location. This patient 
had undergone previous ablations of a right posteroseptal 
accessory pathway and a right atriofascicular pathway in the 
posterolateral base, which were suspected to have played roles in 
the discrepancy between the two diagnoses. For the patient with 
apical LV location, ECGI imaged the mid-anterior LV as the location. 
This patient had a large LV apical aneurysm and several different VT 
morphologies with discrepancy possibly from the comparison of two 
different VTs sequentially imaged non-invasively followed by invasively. 
The arrhythmia mechanism was correctly diagnosed as focal (18 out 
of 18) and re-entrant (5 out of 5) in 100 % of patients based 
on the centrifugal and early-meeting-late patterns of activation, 
respectively. Invasive findings were compared with ECGI for 
determining epicardial versus non-epicardial locations of VT. As a 
result of the thin tissue in the outflow tract, patients with outflow 
tract were excluded. Of the 13 remaining patients, the invasive study 
determined the location to be endocardial in six, epicardial in five and 
mid-myocardial in two. All five patients with epicardial location had QS 
wave at the site of earliest activation (100 %), indicative of epicardial 
origin, non-invasively. Among the patients with a non-epicardial 
location, the local electrogram at the earliest site demonstrated 
a small r wave in seven of eight (88 %). The spatial accuracy of 
non-invasive imaging has been cited as a possible limitation, but the 
most significant weakness of the ventricular imaging involves 
the variable contributions of the endocardium and epicardium to the 
arrhythmia as much as the septal location of the arrhythmia. 
The earliest epicardial activation of VT may not accurately identify the 
location of an endocardial circuit. Also, currently slow, discontinuous 
delayed systolic/diastolic conduction inside the scar (late potential) 
may not be visualised.
In another multicentre study, 35 premature ventricular beats imaged 
non-invasively were accurately diagnosed in 100 % of patients with 
regard to chamber identification and focal mechanism.17
Ventricular Pre-excitation
Ghosh et al. imaged 14 paediatric patients with Wolff-Parkinson-
White syndrome and no other congenital disease, with ECGI a day 
before successful catheter ablation.18 The pre-excitation sites were 
consistent with sites of successful ablation (five left lateral, four left 
posteroseptal, two right posteroseptal, one right mid-septal, one right 
posterior and one in the coronary sinus diverticulum), qualitatively, in 
all cases to within a one-hour arc of each atrioventricular annulus. 
In a patient with two closely-situated accessory pathways, ECGI 
showed two contiguous epicardial breakthroughs. Based on the 
electrogram morphology (QS versus rS patterns), ECGI could 
differentiate between the endocardial (12) and epicardial (two) 
locations of the accessory pathways. 
Ghosh et al. also reported qualitatively accurate ECGI imaging of 
accessory pathways observed in patients with structurally abnormal 
hearts like hypertrophic cardiomyopathy, Ebstein’s anomaly and status 
post repair of a univentricular heart.19–21 In another multicentre study, 
seven patients with Wolff-Parkinson-White syndrome imaged non-invasively 
were accurately diagnosed with regard to the identification of the 
ventricular epicardial breakthrough site of pre-excitation (delta) wave17  
(see Figure 7).
Fast/Rapid Mapping
Being a non-invasive system, ECM is a mapping technology that can 
be applied bedside, potentially providing an electrophysiologist with 
all the information necessary to plan the procedure before ablation 
is undertaken. Therefore, we evaluated the clinical impact of ECM on 
reducing the procedure time, fluoroscopic exposure and in general 
the efficacy of the ablation procedure by undertaking the ablation 
of premature ventricular beats (RV-5, LV-5), atrial tachycardia and 
ectopic beats (RA-0, LA-3), and manifest accessory pathways (RV-2, 
LV-4) guided exclusively by the pre-procedural ECM-based diagnostic 
mapping. All ventricular ectopics were diagnosed accurately and 
successfully ablated. One perimitral AT could not be diagnosed 
by ECM imaging. An accessory pathway successfully ablated in 
the left mid-septal region was diagnosed as left anterolateral 
pathway based on its earliest epicardial breakthrough. A right 
posterolateral accessory pathway was accurately diagnosed but 
could not be successfully ablated at the index procedure. Excluding 
these three arrhythmias, the median times for the procedure, cardiac 
catheterisation to permanent arrhythmia elimination, radiofrequency 
application and fluoroscopic exposure were 70.0 minutes (min), 19.7 
min, 5.6 min and 11.4 min, respectively. Although the observational 
study holds promise, randomised studies are necessary to ascertain 
the benefits of fast mapping over invasive mapping with or without 
electroanatomic systems.
Clinical Application in Heart Failure
Besides non-invasive identification of sources, ECM has been of clinical 
value in cardiac resynchronisation therapy (CRT) for heart failure. CRT using 
biventricular pacing has been developed to restore electromechanical 
synchrony and improve cardiac performance in patients with refractory 
heart failure. However, it has been clinically beneficial to 65–70  % 
of patients who receive it. Being an electrical (pacing) approach, 
detailed electrical information during CRT is critical in understanding its 
mechanism and clinical outcome. Electrocardiomapping is a superior 
tool than standard ECG to non-invasively obtain this information.22,23 
Most remarkable about ECM is its ability to guide lead placement to 
the area of latest electrical activation perprocedurally (see Figure 8). 
Silva et al. and Ghosh et al. computed the left ventricular electrical 
dyssynchrony index as the standard deviation of local activation 
times at 500 sites on the left ventricular epicardium based on which 
the CRT responders could be pre-identified among a wide range of 
heart failure patients. Current guidelines-based recipients of CRT who 
benefited from the therapy had high dyssynchrony index at baseline, 
which dropped substantially post-therapy. Non-responders had low 
dyssynchrony index at baseline or did not substantially drop the 
index-value post resynchronisation.24,25 
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Conclusion
Clinical experience with the novel, non-invasive electrocardiomapping 
system demonstrates the feasibility of accurately identifying 
the cardiac chamber harbouring the arrhythmia and defining the 
mechanism of a wide range of atrial and ventricular arrhythmias, 
as well as disorders of electrical synchrony. The widespread 
pre- and per-procedural clinical utility of the system in panoramic 3D 
mapping of various simple and complex tachyarrhythmias, including 
those arising post-AF ablation, and in describing the global cardiac 
activation patterns in complex conduction problems edges past 
12-lead ECG, the current standard of care for all electrical abnormalities 
of the heart. Rapid, reliable and the  single beat/cycle-based diagnostic 
ability of the system expresses its potential to reduce ablation, 
fluoroscopic and procedural times. n
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